Studies involving BXD RI panel          

Filter by:
Data set Procedure What's in this data set Panel Sex Age (weeks) Year
Auwerx1 body temperature
with high-fat diet
In cold room: 0, 1, 2, 3, 4, 5, 6 h. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 body weight
with high-fat diet
8-29 wks of age. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 cell signaling molecule detection
with high-fat diet
INF-gamma, interleukins, monocyte chemoattractant, macrophage inflammatory protein, T cell RANTES, TNF-alpha. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 complete blood count
with high-fat diet
RBC, hematocrit. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 glucose tolerance
with high-fat diet
Glucose post oral gavage: 0, 15, 30, 45, 60, 90, 120, 150, 180 min plus area under curve. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 hormone quantification
with high-fat diet
Glucose post oral gavage: 0, 15, 30 min plus area under curve. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 intake monitoring
with high-fat diet
Food intake. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 lipid profile
with high-fat diet
Cholesterol, HDL, LDL, free fatty acids, triglyceride. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 metabolic panel
with high-fat diet
Enzymes, bile acid, proteins, creatinine, glucose, iron, lactate. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 monitoring system
with high-fat diet
Oxygen consumption and respiratory exchange ratio (RER); activity. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 NMR
with high-fat diet
Body composition. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 organ weights
with high-fat diet
Skeletal muscle, soleus muscle, heart, kidney, liver, various fat pads. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 running wheel monitoring
with high-fat diet
Distance traveled, speed. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 tail cuff
with high-fat diet
Blood pressure and heart rate. BXD w/par   (57) m 8-29 wks 2016
Auwerx1 treadmill endurance test
with high-fat diet
Distance traveled. BXD w/par   (57) m 8-29 wks 2016
CGD-MDA2 genotyping SNP profiling, 470,000+ genomic locations, 1-19,X,Y,MT. BXD w/par   (92) m 2014
Chesler1 nociception assay Tail clip, Von Frey, Hargreaves, tail withdrawal, hot plate. BXD   (61) both 7-15wks 2010
Crusio1 behavior observation Inter-male agression. BXD w/par   (55) both 10-16wks 2018
Crusio1 body weight Body weight BXD w/par   (55) both 10-16wks 2018
Crusio1 histopathology Hippocampal histology. BXD w/par   (55) both 10-16wks 2018
Crusio1 open field test Locomotor activity and exploratory behavior. 20 min test. BXD w/par   (55) both 10-16wks 2018
Crusio1 organ weights Brain weight. BXD w/par   (55) both 10-16wks 2018
Crusio1 radial maze Spatial learning. BXD w/par   (55) both 10-16wks 2018
DiCurzio1 body weight Body weight BXD w/par   (66) both 10wks 2010
DiCurzio1 histopathology Adrenal glands. BXD w/par   (66) both 10wks 2010
DiCurzio1 organ weights Adrenal weight. BXD w/par   (66) both 10wks 2010
Donahue14 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. BXD   (42) f 3-60wks 2011
Donahue17 colony observation Reproduction, fecundity. Litter size, litter interval, percent weaned, pup sexes. BXD   (30) f 3-57wks 2011
HMDPpheno1 DXA Bone mineral density (whole body, femur, spine). HMDP   (96) m 16wks 2011
HMDPpheno10 metabolite quantification Liver metabolic profiling. Molecular measures of nucleotides, peptides. 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno11 histopathology
with high-fat high-cholesterol diet
Aortic lesion size after 16 wks on high-fat diet. HMDP hAPOE and hCETP transgenic   (103) both 23-25 wks 2015
HMDPpheno2 lipid profile Cholesterol, HDL, non-HDL, triglycerides, free fatty acids. 16h fast, plasma. HMDP   (99) m 16wks 2010
HMDPpheno2 NMR Percent fat. HMDP   (99) m 16wks 2010
HMDPpheno3 tail cuff Heart rate and blood pressure. Conscious mice. HMDP   (58) m 9-10wks 2012
HMDPpheno4 fear conditioning test Contextual fear, cued fear. HMDP   (94) m 10wks 2011
HMDPpheno5 complete blood count Hematology. HMDP   (83) m 16wks 2013
HMDPpheno6 metabolite quantification Liver metabolic profiling. Molecular measures of amino acids. 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno7 metabolite quantification Liver metabolic profiling. Molecular measures of carbs, cofactors, vitamins, energy, xenobiotics. 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno8 metabolite quantification Liver metabolic profiling. Molecular measures of lipids (non-lysolipids). 16h fast. HMDP   (106) m 16wks 2014
HMDPpheno9 metabolite quantification Liver metabolic profiling. Molecular measures of lipids (lysolipids). 16h fast. HMDP   (106) m 16wks 2014
Jentsch1 operant conditioning chamber Reversal learning test. Impulsivity, acquisition, reversal, conditioning. Performance and latency. BXD w/par   (53) m 17wks 2011
Jentsch2 operant conditioning chamber
with cocaine
Intravenous self-administration of cocaine via activation of levers, and locomotor activity. BXD   (4) both 8-17wks 2013
Rosen1 histopathology Midsagittal area of corpus callosum. BXD w/par   (78) both various 2012
Rosen2 histopathology Lateral septal nucleus volume. BXD w/par   (71) both various 2012
Schalkwyk2 RNA expression profiling Hippocampal microRNA expression. Normalized data. BXD w/par   (26) m 15-16wks 2012
Schughart2 body weight
with influenza A (H1N1) virus
Influenza A (H1N1) virus vs. baseline. Several timepoints.. BXD w/par   (56) f 9-18wks 2012
Schughart2 health assessment
with influenza A (H1N1) virus
Survival rate, susceptibility, influenza A (H1N1) virus. BXD w/par   (56) f 9-18wks 2012
Spijker1 acoustic startle test Acoustic startle response, prepulse inhibition. BXD w/par   (45) m 8wks 2011
Spijker1 choice serial reaction time task Choice serial reaction time task. Impulsivity, attention, cognitive flexibility behavior. BXD w/par   (45) m 8wks 2011
UCLA1 genotyping SNP profiling, 132,000+ genomic locations, 1-19,X HMDP   (248) both 2018